Lutz Stefan is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $18K.
Profile
Stefan Lutz serves as the Chief Scientific Officer (CSO) at Codexis, Inc., a biotechnology company that provides enzymatic solutions to enable scalable therapeutics manufacturing using its CodeEvolver platform. This role is reflected in Codexis SEC filings, with no insider purchases or sales reported as of the most recent filing date (2026-01-08).
Role
Insider
Notability
45/100
Board memberships
Codexis, Inc.
Awards & honors
Led scientific strategy and research initiatives as CSO at Codexis
Oversaw CodeEvolver platform development and enzyme discovery
Contributed to scalable enzyme manufacturing solutions for therapeutics
Stefan Lutz serves as the Chief Scientific Officer (CSO) at Codexis, Inc., a biotechnology company that provides enzymatic solutions to enable scalable therapeutics manufacturing using its CodeEvolver platform. This role is reflected in Codexis SEC filings, with no insider purchases or sales reported as of the most recent filing date (2026-01-08).…
Has Lutz Stefan been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($18K) across all tracked filings.
Where can I see all of Lutz Stefan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
